| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |